Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Self-reported limitations in physical function are common 6 months after out-of-hospital cardiac arrest

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Training Contemporary levels of cardiopulmonary resuscitation training in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Out-of-hospital cardiac arrest: Does rurality decrease chances of survival?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Temporal variation in out-of-hospital cardiac arrest occurrence in individuals with or without diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Marion Moseby-Knappe
  • Helena Levin
  • Kaj Blennow
  • Susann Ullén
  • Henrik Zetterberg
  • Gisela Lilja
  • Josef Dankiewicz
  • Janus Christian Jakobsen
  • Alice Lagebrant
  • Hans Friberg
  • Alistair Nichol
  • Kate Ainschough
  • Glenn M Eastwood
  • Matt P Wise
  • Matthew Thomas
  • Thomas Keeble
  • Alain Cariou
  • Christoph Leithner
  • Christian Rylander
  • Joachim Düring
  • Jan Bělohlávek
  • Anders Grejs
  • Ola Borgquist
  • Johan Undén
  • Maryline Simon
  • Vinzent Rolny
  • Alex Piehler
  • Tobias Cronberg
  • Niklas Nielsen
Vis graf over relationer

Background: Several biochemical markers in blood correlate with the magnitude of brain injury and may be used to predict neurological outcome after cardiac arrest. We present a protocol for the evaluation of prognostic accuracy of brain injury markers after cardiac arrest. The aim is to define the best predictive marker and to establish clinically useful cut-off levels for routine implementation.

Methods: Prospective international multicenter trial within the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial in collaboration with Roche Diagnostics International AG. Samples were collected 0, 24, 48, and 72 hours after randomisation (serum) and 0 and 48 hours after randomisation (plasma), and pre-analytically processed at each site before storage in a central biobank. Routine markers neuron-specific enolase (NSE) and S100B, and neurofilament light, total-tau and glial fibrillary acidic protein will be batch analysed using novel Elecsys® electrochemiluminescence immunoassays on a Cobas e601 instrument.

Results: Statistical analysis will be reported according to the Standards for Reporting Diagnostic accuracy studies (STARD) and will include comparisons for prediction of good versus poor functional outcome at six months post-arrest, by modified Rankin Scale (0-3 vs. 4-6), using logistic regression models and receiver operating characteristics curves, evaluation of mortality at six months according to biomarker levels and establishment of cut-off values for prediction of poor neurological outcome at 95-100% specificities.

Conclusions: This prospective trial may establish a standard methodology and clinically appropriate cut-off levels for the optimal biomarker of brain injury which predicts poor neurological outcome after cardiac arrest.

TidsskriftResuscitation plus
Sider (fra-til)100258
StatusUdgivet - jun. 2022

Bibliografisk note

© 2022 The Authors.

ID: 78605817